Concepedia
Statistics
Publications
6
Citations
289
H-Index
Active since
2004
Affiliations
Bristol-Myers Squibb (United States)(Current)
Exelixis (United States)
Colin Chong is an author at Bristol-Myers Squibb (United States).
Publications per year
2004–2022
BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis <i>In Vitro</i> and Shows Antitumor Activity <i>In Vivo</i> in Hematologic Malignancies
Michelle Kuhne, Tanya Mulvey, Blake Belanger et al. · Clinical Cancer Research · 2012 · 207 citations
Discovery of Non-Nucleotide Small-Molecule STING Agonists <i>via</i> Chemotype Hybridization
Emily C. Cherney, Liping Zhang, Julian B. Lo et al. · Journal of Medicinal Chemistry · 2022 · 31 citations · Full text
Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill et al. · Molecular Cancer Therapeutics · 2022 · 19 citations · Full text
Synthesis and Biological Evaluation of a Carbamate-Containing Tubulysin Antibody–Drug Conjugate
Heng Cheng, Qiang Cong, Dan Dervin et al. · Bioconjugate Chemistry · 2020 · 12 citations
A profile of the caring attributes of Hong Kong and Thailand psychiatric nurses
David Arthur, Colin Chong, Darunee Rujkorakarn et al. · International Journal of Mental Health Nursing · 2004 · 10 citations
1–5 of 6